Drug
Digoxin clinical trials
Also written Lanoxin.
- studies test it
- 146
- open now
- 10
- in phase 3
- 4
- first study started
- 2006
Keep track of what changes. Save the Digoxin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
- Lanoxin
- 16
Other names
Studies by the year they started
145 studies that test it; most in 2014 (12)
| Year | Studies |
|---|---|
| 2006 | 5 |
| 2008 | 6 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 7 |
| 2013 | 5 |
| 2014 | 12 |
| 2015 | 9 |
| 2016 | 6 |
| 2017 | 9 |
| 2018 | 1 |
| 2019 | 7 |
| 2020 | 11 |
| 2021 | 11 |
| 2022 | 7 |
| 2023 | 12 |
| 2024 | 8 |
| 2025 | 12 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 110
- Phase 2
- 18
- Phase 3
- 4
- Phase 4
- 8
- No phase
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 100 · Other 46
Boehringer Ingelheim (13) · Eli Lilly and Company (5) · AstraZeneca (5) · Bristol-Myers Squibb (4) · Novo Nordisk A/S (3) · Jiangsu HengRui Medicine Co., Ltd. (3) · Yale University (3) · Celgene (3)
Often tested with
Tested in the same studies.
Rosuvastatin (34) · Midazolam (27) · Metformin (26) · Warfarin (16) · Omeprazole (9) · Furosemide (8) · Atorvastatin (8) · Itraconazole (7)
Studies
Open first, then newest update. How each study uses Digoxin is read from its arms, and is right about nine times in ten.
Testing it · 146
- A Phase I Study of the Interaction of D-2570 With Other Drugs in Healthy AdultsNot yet recruitingPhase 1InventisBio Co., LtdNCT07875842Written as Digoxin
- Digoxin Medulloblastoma StudyRecruitingPhase 2H. Lee Moffitt Cancer Center and Research InstituteNCT06701812Written as Digoxin
- Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or ObesityRecruitingPhase 1The United Bio-Technology (Hengqin) Co., Ltd.NCT07785934Written as Digoxin
- Digoxin After Acute Heart Failure (DIG-DICA)RecruitingPhase 4Hospital General de Agudos "Dr. Cosme Argerich"NCT07321509Written as Digoxin
- Digoxin In NASH (CODIN)RecruitingPhase 2Yale UniversityNCT06588699Written as Digoxin
- Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and DigoxinNot yet recruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07502001Written as Digoxin
- Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 InjectionRecruitingPhase 1Gan & Lee Pharmaceuticals.NCT07128888Written as GZR18 injection,digoxin tablets, rosuvastatin calcium tablets and warfarin sodium tablets
- Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal CancerNot yet recruitingPhase 1/2Fudan UniversityNCT07025850Written as Digoxin
- Digoxin and Senolysis in Heart Failure and Diabetes MellitusNot yet recruitingPhase 2University of LeedsNCT06240403Written as Digoxin 0.125 MG
- A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.Not yet recruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06601517Written as Digoxin
- Digoxin Short Term Treatment Assessment Randomized Trial in AHFCompletedPhase 3University of MonastirNCT02544815Written as Digoxin
- FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic CancerTerminatedPhase 2University of NebraskaNCT04141995Written as Digoxin
- A Research Study of the Effect of Etavopivat on Other Drugs in Healthy ParticipantsCompletedPhase 1Novo Nordisk A/SNCT06813924Written as Digoxin
- Digoxin In Treatment of Alcohol Associated HepatitisTerminatedPhase 2Yale UniversityNCT05014087Written as Intravenous digoxin
- A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.CompletedPhase 1AbbVieNCT07567781Written as Digoxin
- PK/PD of Digoxin in Infants With SVHDCompletedPhase 1/2Duke UniversityNCT06613477Written as PK/PD Model Based Dosing of Digoxin in Infants with Single Ventricle Heart Disease
- Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)CompletedPhase 2Massachusetts General HospitalNCT07047209Written as Digoxin
- A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and DigoxinCompletedPhase 1Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT07118215Written as Digoxin
- A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight SubjectsCompletedPhase 1Shandong Suncadia Medicine Co., Ltd.NCT07269756Written as Digoxin Tablets
- Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin HydrochlorideCompletedPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT04621669Written as digoxin
See all 146 studies that test Digoxin →
Given in every arm · 19 — Digoxin is usual care beside what is tested
- FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3RecruitingPhase 1Eli Lilly and CompanyNCT05614739Written as Digoxin
- A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT06186622Written as Digoxin
- A Study of Calderasib (MK-1084) With Midazolam and Digoxin in Healthy Participants (MK-1084-009)CompletedPhase 1Merck Sharp & Dohme LLCNCT06575933Written as Digoxin
- A Study of Imlunestrant (LY3484356) in Female Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT05444556Written as Digoxin
- The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of DigoxinCompletedPhase 1Bial - Portela C S.A.NCT02172742Written as Digoxin
- A Clinical Trial to Investigate the Clinical Drug-Drug Interaction of Divarasib With Probe Substrates of P-Glycoprotein and Breast Cancer Resistance Protein in Healthy ParticipantsCompletedPhase 1Genentech, Inc.NCT06677957Written as Digoxin
- A Study of the Effect of Nemtabrutinib (MK-1026) on the Plasma Levels of Digoxin in Healthy Participants (MK-1026-012)CompletedPhase 1Merck Sharp & Dohme LLCNCT06625827Written as Digoxin
- Phenotyping of High Dose RifampicinCompletedPhase 1Radboud University Medical CenterNCT04525235Written as phenotyping cocktail
- Bexagliflozin Drug/Drug Interaction Study With DigoxinCompletedPhase 1TheracosNCT03197324Written as Digoxin
- A Study of Evacetrapib and Digoxin in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT01897493Written as Digoxin
- A Clinical Trial of Patients With MelanomaWithdrawnPhase 1University of Texas Southwestern Medical CenterNCT02915666Written as Digoxin Combination
- Phase 1 Drug Interaction Study of the Effect of Apixaban on the PK of Digoxin in Healthy SubjectsCompletedPhase 1Bristol-Myers SquibbNCT02262520Written as Digoxin
- Pharmacokinetics, Safety and Tolerability of Digoxin With or Without Co-administration of BI 1356 in Healthy VolunteersCompletedPhase 1Boehringer IngelheimNCT02183402Written as Digoxin
- Digoxin Dosing in Heart Failure: A Simplified Nomogram Versus Standard CareCompletedPhase 4University of Illinois at ChicagoNCT01005602Written as Digoxin
- A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of Digoxin in Healthy Volunteers.CompletedPhase 1Johnson & Johnson Pharmaceutical Research & Development, L.L.C.NCT01714206Written as Digoxin 0.5 mg
- Study Evaluating The Potential Effect Of Multiple Doses Of Neratinib On The Pharmacokinetics Of A Single Dose Of DigoxinCompletedPhase 1Puma Biotechnology, Inc.NCT00860223Written as Digoxin
- A Drug-Drug Interaction Study of Digoxin and PA21CompletedPhase 1Vifor PharmaNCT01477411Written as Digoxin
- Investigate the Effect of AZD1656 on the Pharmacokinetics of Digoxin in Type 2 Diabetes Mellitus PatientsCompletedPhase 1AstraZenecaNCT01103622Written as Digoxin
- Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy SubjectsCompletedPhase 1PfizerNCT00831506Written as digoxin
As the comparator · 6 — what is tested is compared with Digoxin
- Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)RecruitingPhase 3Advenchen Laboratories, LLCNCT03016819Written as Digoxin (0.25mg)
- New Horizons for the Treatment of Cardiomyopathy in ChildrenTerminatedNot applicableDamascus UniversityNCT04893629Written as Digoxin+furosemide+captopril
- IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study).CompletedPhase 3Adolfo FontenlaNCT03718273Written as Digoxin
- Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection FractionStatus unknownPhase 3Chun-Yao HuangNCT04308031Written as Digoxin 0.25 mg
- Digoxin Withdrawal in Stable Heart FailureCompletedNot applicableThe AlfredNCT01398371Written as Digoxin
- Spanish Atrial Fibrillation And Resynchronization StudyCompletedPhase 4Hospital Clinic of BarcelonaNCT01181414Written as Beta blocker/digoxine/amiodarone
Codes
What other systems call Digoxin · ClinicalTrials.gg INT007353
- MeSH (NLM) D004077DigoxinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 73K4184T59DIGOXINConfirmed FDA, NLM, Wikidata
- RxNorm 3407Confirmed FDA, Wikidata
- Wikidata Q422222digoxinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C28990DigoxinOne source FDA
- DrugBank DB00390One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D004077 | Digoxin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 73K4184T59 | DIGOXIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3407 | — | Confirmed FDA, Wikidata |
| Wikidata | Q422222 | digoxin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C28990 | Digoxin | One source FDA |
| DrugBank | DB00390 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.